Graftless TSFE Via Self-tapping Implants
Transcrestal Graftless Schneiderian Membrane Elevation by Self-tapping Dental Implant
Sana'a University
20 participants
Sep 9, 2024
INTERVENTIONAL
Conditions
Summary
This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height. The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.
Eligibility
Inclusion Criteria7
- Adults aged 18-80 years.
- Patients with edentulous posterior maxilla.
- Residual bone height approximately 4-6 mm.
- Indicated for transcrestal sinus membrane elevation.
- Good general health (ASA I or II).
- Ability to provide written informed consent.
- Willingness to attend follow-up visits.
Exclusion Criteria8
- Severe systemic diseases (ASA III or above).
- Uncontrolled diabetes mellitus.
- Active sinus pathology.
- History of radiotherapy in the head and neck region.
- Heavy smokers (\>10 cigarettes/day).
- Pregnancy or lactation.
- Untreated periodontal disease.
- \. Poor oral hygiene.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A minimally invasive transcrestal approach for sinus membrane elevation without graft material, followed by simultaneous placement of a 10 mm length and 4-4.5 mm diameter dental implant in the posterior maxilla with residual bone height of approximately 5 mm.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07424742